Cobenfy, a schizophrenia drug, shows promise in treating Alzheimer’s disease.
Bristol Myers Squibb Believes Alzheimer’s is Largest Market for Schizophrenia Drug Cobenfy Bristol Myers Squibb believes that Alzheimer’s disease is the largest…
Bristol Myers Squibb Believes Alzheimer’s is Largest Market for Schizophrenia Drug Cobenfy Bristol Myers Squibb believes that Alzheimer’s disease is the largest…
Eli Lilly and Company Announces Approval of Kisunla Treatment for Early Symptomatic Alzheimer’s Disease in China Eli Lilly and Company has announced…
That’s Just Not Her: New Study Shows Falling for Financial Scams Can Predict Alzheimer’s Researchers at the University of Southern California (USC)…
As the Belly Grows, Brain Shrinks: Study Finds Link Between Obesity and Alzheimer’s A new study has found that as a person’s…
As the size of a person’s belly grows, the memory center of their brain shrinks and beta amyloid and tau may appear,…